
Bharat Biotech’s intranasal heterologous booster dose likely to hit market in February first week, Health News, ET HealthWorld
New Delhi: Hyderabad-based Bharat Biotech‘s intranasal heterologous booster dose is likely to be available in the market in the first week of February only, sources...